eMC Medicine Guides  
The electronic Medicines Compendium (eMC) contains information about UK licensed medicines.
go to eMC homepage
Search for:  
  Advanced Search

AstraZeneca UK Limited
Horizon Place, 600 Capability Green, Luton, Bedfordshire, LU1 3LU
Telephone: +44 (0)1582 836 000
Fax: +44 (0)1582 838 000
Medical Information Direct Line: +44 (0)1582 836 836
Medical Information e-mail: medical.informationuk@astrazeneca.com
Customer Care direct line: +44 (0)1582 837 837
Medical Information Fax: +44 (0)1582 838 003

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 24/08/2011
PIL SEROQUEL 25 mg, 100 mg, 150 mg, 200 mg, 300 mg film-coated tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 24/08/2011 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 16/03/2011 and displayed until 24/08/2011
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to drug interactions
Updated on 17/02/2010 and displayed until 16/03/2011
Reasons for adding or updating:
  • Change of trade or generic name
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to dosage and administration
Updated on 14/10/2009 and displayed until 17/02/2010
Reasons for adding or updating:
  • Change to side-effects
Updated on 18/08/2009 and displayed until 14/10/2009
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 30/03/2009 and displayed until 18/08/2009
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 07/01/2009 and displayed until 30/03/2009
Reasons for adding or updating:
  • Change to side-effects
Updated on 22/07/2005 and displayed until 07/01/2009
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to date of revision
Updated on 20/02/2004 and displayed until 22/07/2005
Reasons for adding or updating:
  • Update to PIL
Updated on 17/12/2003 and displayed until 20/02/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 26/09/2002 and displayed until 17/12/2003
Reasons for adding or updating:
  • Update to PIL
Updated on 16/07/2002 and displayed until 26/09/2002
Reasons for adding or updating:
  • Update to PIL
Updated on 17/09/2001 and displayed until 16/07/2002
Reasons for adding or updating:
  • Update to PIL
Updated on 14/09/2000 and displayed until 17/09/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
  quetiapine fumarate